Neuberger Berman Group
IDYA icon

Neuberger Berman Group’s IDEAYA Biosciences IDYA Stock Holding History

Neuberger Berman Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-120,603
Closed -$4.02M – 2376
2026
Q1 		$4.02M Buy
120,603
+9,327
+8% +$313K ﹤0.01% 1022
2025
Q4 		$3.85M Buy
+111,276
New +$3.55M ﹤0.01% 1021
2025
Q1 		– Sell
-165,527
Closed -$4.25M – 2015
2024
Q4 		$4.25M Buy
165,527
+44,588
+37% +$1.26M ﹤0.01% 992
2024
Q3 		$3.83M Buy
120,939
+30,530
+34% +$1.16M ﹤0.01% 995
2024
Q2 		$3.17M Buy
90,409
+6,654
+8% +$264K ﹤0.01% 1005
2024
Q1 		$3.68M Buy
+83,755
New +$3.6M ﹤0.01% 999

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Neuberger Berman Group's IDYA Position: Q2 2026 in Review

Neuberger Berman Group sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 120,603 shares — an estimated $4.02M sold.

Neuberger Berman Group first reported a position in IDYA in Q1 2024 and held it in 6 quarters. The position peaked at $4.25M in Q4 2024. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Neuberger Berman Group reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Neuberger Berman Group sold 120,603 IDEAYA Biosciences shares in Q2 2026, an estimated $4.02M.
  • Neuberger Berman Group first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 6 quarters.
  • Neuberger Berman Group's IDEAYA Biosciences position peaked at $4.25M in Q4 2024.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.